Log In
Print
BCIQ
Print
Print this Print this
 

Oncotype DX prostate cancer assay

Also known as: Prostate cancer test

  Manage Alerts
Collapse Summary General Information
Company Genomic Health Inc.
DescriptionProstate biopsy test that measures the expression of 17 genes to guide selection of active surveillance or surgery/radiation as a treatment course for early stage prostate cancer
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDistinguish between aggressive disease requiring surgery from less aggressive disease that may undergo active surveillance in patients with early-stage prostate cancer; Predict adverse pathology in patients with early stage prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today